MEDIGREX
Timeline
35 events since 1999Board
Filings
Financial
Establishments
200020052010201520202025
Deadline for the 2026 accounts: 30-04-2027
2026
Annual accounts 2025 filed PDFabbreviated format · 3 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0465660871
Annual accounts 2024 filed PDFabbreviated format · 6 days before the deadline
2024
Highest result from 2006 to 2025 net €218,115 ▲33.3% The operating result of €303,764 and the net result of €218,115 are both a record.
Annual accounts 2023 filed PDFabbreviated format · 42 days before the deadline
2023
1 director appointed, 2 resignationsResignations: KEMPEN PHARMA and KEMPEN Ineke · Appointment: KEMPEN PHARMA · Permanent representative: KEMPEN Ineke · General meeting of 11-05-20235 points ▸
- General meeting, 11-05-2023
- Director resignation, KEMPEN PHARMA
- Director resignation, KEMPEN Ineke
- Director appointment, KEMPEN PHARMA
- Permanent representative, KEMPEN Ineke
- The deed holds 2 more points.
2022
Annual accounts 2021 filed PDFabbreviated format · 4 days before the deadline
2021
Annual accounts 2020 filed PDFabbreviated format · 4 days before the deadline
2020
- Director reappointment, BVBA Kempen Pharma
- Director reappointment, Kempen Ineke
- Director reappointment, BVBA Kempen Pharma (managing director)
Annual accounts 2019 filed PDFabbreviated format · 2 days before the deadline
2019
Annual accounts 2018 filed PDFabbreviated format · 1 day before the deadline
2018
Annual accounts 2017 filed PDFabbreviated format · 35 days before the deadline
2017
Annual accounts 2016 filed PDFabbreviated format · 27 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 9 days before the deadline
2015
Annual accounts 2014 filed PDFabbreviated format · 22 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 20 days before the deadline
2013
First establishment Medigrex nv, Bredabaan (Centrum) 403, Wuustwezel
Annual accounts 2012 filed PDFabbreviated format · 6 days before the deadline
2012
Liquidity more than doubled current ratio 2.29 The current ratio rises from 0.78 to 2.29. Short-term debt falls from €879,717 to €309,445.
Annual accounts 2011 filed PDFabbreviated format · 1 day late
2011
Annual accounts 2010 filed PDFabbreviated format · 8 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 11 days before the deadline
2009
Equity above €500,000 equity €583,190 ▲37.6% After 3 profitable years in a row, equity reaches €583,190.
Annual accounts 2008 filed PDFabbreviated format · 1 day before the deadline
2008
Annual accounts 2007 filed PDFabbreviated format · 22 days late
2007
Back to profit net €153,143 The net result is €153,143, after one loss-making year.
Annual accounts 2006 filed PDFabbreviated format · 19 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2003
Annual accounts 2002 filed PDFabbreviated format
2002
Annual accounts 2001 filed PDFabbreviated format
2001
Annual accounts 2000 filed PDFabbreviated format
2000
Annual accounts 1999 filed PDFabbreviated format
1999
Incorporation published on 02-04-1999
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank